Junshi Biosciences Announces Phase 3 Study of Toripalimab Combined with Bevacizumab for the First-line Treatment of Advanced Hepatocellular Carcinoma Meets Primary Endpoint
Globe Newswire12-06-2024, 09:06
York University and Canadian Black Chamber of Commerce 14-03-2023, 02:12